Острые нарушения мозгового кровообращения у лиц с дифференцированными дисплазиями соединительной ткани


DOI: https://dx.doi.org/10.18565/therapy.2021.5.88-95

Н.В. Пизова, Н.А. Пизов, О.А. Скачкова, В.А. Шадричев

ФГБОУ ВО «Ярославский государственный медицинский университет» Минздрава России
Аннотация. Острые нарушения мозгового кровообращения (ОНМК) являются распространенными заболеваниями у лиц разного пола и возраста. Причины ОНМК многообразны и отличаются в зависимости от возрастных групп. В настоящее время отмечается увеличение частоты развития инсульта у молодых пациентов. В молодом возрасте ОНМК могут развиваться у лиц с врожденной патологией соединительной ткани. Углубленно рассмотрены такие типичные наследственные заболевания соединительной ткани, как синдром Марфана, синдром Элерса–Данлоса, синдром Лойса–Дитца и эластическая псевдоксантома. Представлены диагностические критерии этих заболеваний, данные об их распространенности и особенности сопутствующих ОНМК.
Ключевые слова: эластическая псевдоксантома, синдром Лойса–Дитца, синдром Элерса–Данлоса, острые нарушения мозгового кровообращения, наследственные заболевания соединительной ткани, синдром Марфана
Полный текст статьи доступен
в "Библиотеке Врача"

Литература


  1. Struijs J.N., van Genugten M.L., Evers S.M. et al. Future costs of stroke in the Netherlands: the impact of stroke services. Int J Technol Assess Health Care Fall. 2006; 22(4): 518–24. doi: 10.1017/S0266462306051464.

  2. Krishnamurthi R.V., Moran A.E., Feigin V.L. et al. GBD 2013 Stroke Panel Experts Group. Stroke prevalence, mortality and disability-adjusted life years in adults aged 20–64 years in 1990–2013: Data from the global burden of disease 2013 study. Neuroepidemiology. 2015; 45(3): 190–202. doi: 10.1159/000441098.

  3. Putaala J., Metso A.J., Metso T.M. et al. Analysis of 1008 consecutive patients aged 15 to 49 with first-ever ischemic stroke: the Helsinki Young Stroke Registry. Stroke. 2009; 40(4): 1195–203. doi: 10.1161/STROKEAHA.108.529883.

  4. Kolominsky-Rabas P.L., Sarti C., Heuschmann P.U. et al. A prospective community-based study of stroke in Germany – the Erlangen Stroke Project (ESPro): incidence and case fatality at 1, 3, and 12 months. Stroke. 1998; 29(12): 2501–06. doi: 10.1161/01.str.29.12.2501.

  5. Loeys B.L., Matthys D.M., De Paepe A.M. Genetic fibrillinopathies. New insights in molecular diagnosis and clinical management. Acta Clin Belg. 2003; 58(1): 3–11. doi: 10.1179/acb.2003.58.1.001.

  6. Meester J.A.N., Verstraeten A., Schepers D. et al. Differences in manifestations of Marfan syndrome, Ehlers–Danlos syndrome, and Loeys–Dietz syndrome. Ann Cardiothorac Surg. 2017; 6(6): 582–94. doi: 10.21037/acs.2017.11.03.

  7. Bascom R., Schubart J.R., Mills S. et al. Heritable disorders of connective tissue: Description of a data repository and initial cohort characterization. Am J Med Genet A. 2019; 179(4): 552–60. doi: 10.1002/ajmg.a.61054.

  8. Kim S.T., Brinjikji W., Lanzino G., Kallmes D.F. Neurovascular manifestations of connec-tive-tissue diseases: A review. Interv Neuroradiol. 2016; 22(6): 624–37. doi: 10.1177/1591019916659262.

  9. Judge D.P., Dietz H.C. Marfan’s syndrome. Lancet. 2005; 366(9501): 1965–76. doi: 10.1016/S0140-6736(05)67789-6.

  10. De Poepe A., Devereux R.B., Dietz H.C. el al. Revised diagnostic criteria for the Marfan syndrome. Am J Med Genet. 1996; 62(4): 417–26. doi: 10.1002/(SICI)1096-8628(19960424)62:4<417::AID-AJMG15>3.0.CO;2-R.

  11. Schievink W.I., Bjornsson J., Piepgras D.G. Coexistence of fibromuscular dysplasia and cystic medial necrosis in a patient with Marfan’s syndrome and bilateral carotid artery dissections. Stroke. 1994; 25(12): 2492–96. doi: 10.1161/01.str.25.12.2492.

  12. Sztajzel R., Hefft S., Girardet C. Marfan’s syndrome and multiple extracranial aneurysms. Cerebrovasc Dis. 2001; 11(4): 346–49. doi: 10.1159/000047665.

  13. Gerhard L., Schmitz-Bauer G. Hinbasiarterinveranderungen bei Marfan-syndrom und idiopathischer media nekrose. Acta Neuropathol. 1973; 26(2): 179–84. doi: 10.1007/BF00697753.

  14. Trotter S.E., Olsen E.G. Marfan’s disease and Erdheim’s cystic medionecrosis: a study of their pathology. Eur Heart J. 1991; 12(1): 83–87. doi: 10.1093/oxfordjournals.eurheartj.a059830.

  15. Wityk R.J., Zanferrari C., Oppenheimer S Neurovascular complications of Marfan syndrome: A retrospective, hospital-based study. Stroke. 2002; 33(3): 680–84. doi: 10.1161/hs0302.103816.

  16. Gott V.L., Greene P.S., Alejo D.E. et al. Replacement of the aortic root in patients with Marfan’s syndrome. N Engl J Med. 1999; 340: 1307–13. doi: 10.1056/NEJM199904293401702.

  17. Hardin C.A. Successful resection of carotid and abdominal aneurysm in two related patients with Marfan’s syndrome. N Engl J Med. 1962; 267: 141–42. doi: 10.1056/NEJM196207192670306.

  18. Lamers R.J.S., Janevski B.K. A forme fruste of Marfan’s syndrome: case history. Angiology. 1990; 41(10): 888–92. doi: 10.1177/000331979004101012.

  19. Lynch D.R., Dawson T.M., Raps E.C., Galetta S.L. Risk factors for the neurologic complica-tions associated with aortic aneurysms. Arch Neurol. 1992; 49(3): 284–88. doi: 10.1001/archneur.1992.00530270098025.

  20. Spittell P.C., Spittell J.A., Joyce J.W. et al. Clinical features and differential diagnosis of aor-tic dissection: experience with 236 cases (1980 through 1990). Mayo Clin Proc. 1993; 68(7): 642–51. doi: 10.1016/s0025-6196(12)60599-0.

  21. Kim S.T., Brinjikji W., Kallmes D.F. Prevalence of intracranial aneurysms in patients with connective tissue diseases: A retrospective study. AJNR Am J Neuroradiol. 2016; 37(8): 1422–26. doi: 10.3174/ajnr.A4718.

  22. Conway J.E., Hutchins G.M., Tamargo R.J. Marfan syndrome is not associated with intracranial aneurysms. Stroke. 1999; 30(8): 1632–36. doi: 10.1161/01.str.30.8.1632.

  23. Schievink W.I. Genetics of intracranial aneurysms. Neurosurgery 1997; 40: 651–62. doi: 10.1097/00006123-199704000-00001.

  24. Verstraeten A., Alaerts M., Van Laer L. et al. Marfan syndrome and related disorders: 25 years of gene discovery. Hum Mutat. 2016; 37(6): 524–31. doi: 10.1002/humu.22977.

  25. Germain D.P. Ehlers–Danlos syndrome type IV. Orphanet J Rare Dis. 2007; 2: 32. doi: 10.1186/1750-1172-2-32.

  26. Beighton P., De Paepe A., Steinmann B. et al. Ehlers–Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers–Danlos Support Group (UK). Am J Med Genet. 1998; 77(1): 31–37. doi: 10.1002/(sici)1096-8628(19980428)77:1<31::aid-ajmg8>3.0.co;2-o.

  27. Prockop D.J., Kivirikko K.I. Collagens: molecular biology, diseases, and potentials for therapy. Annu Rev Biochem. 1995; 64: 403–34. doi: 10.1146/annurev.bi.64.070195.002155.

  28. Schievink W.I., Wijdicks E.F., Michels V.V. et al. Heritable connective tissue disorders in cervical artery dissections: a prospective study. Neurology. 1998; 50(4): 1166–69. doi: 10.1212/wnl.50.4.1166.

  29. Schievink W. Spontaneous dissection of the carotid and vertebral arteries. N Engl J Med. 2001; 344(12): 898–906. doi: 10.1056/NEJM200103223441206.

  30. Malfait F., Francomano C., Byers P. et al. The 2017 international classification of the Ehlers–Danlos syndromes. Am J Med Genet C Semin Med Genet. 2017; 175(1): 8–26. doi: 10.1002/ajmg.c.31552.

  31. Bradley T.J., Bowdin S.C., Morel C.F. et al. The expanding clinical spectrum of extracardiovascular and cardiovascular manifestations of heritable thoracic aortic aneurysm and dissection. Can J Cardiol. 2016; 32(1): 86–99. doi: 10.1016/j.cjca.2015.11.007.

  32. Eagleton M.J. Arterial complications of vascular Ehlers–Danlos syndrome. J Vasc Surg. 2016; 64(6): 1869–80. doi: 10.1016/j.jvs.2016.06.120.

  33. Papagiannis J. Sudden death due to aortic pathology. Cardiol Young. 2017; 27(S1): S36–S42. doi: 10.1017/S1047951116002213.

  34. Byers P.H., Belmont J., Black J. et al. Diagnosis, natural history, and management in vascular Ehlers–Danlos syndrome. Am J Med Genet C Semin Med Genet. 2017; 175: 40–47. doi: 10.1002/ajmg.c.31553.

  35. Castori M., Voermans N.C. Neurological manifestations of Ehlers–Danlos syndrome(s): A review. Iran J Neurol. 2014; 13(4): 190–208.

  36. Shalhub S., Byers P.H., Hicks K.L. et al. A multi-institutional experience in vascular Ehlers–Danlos syndrome diagnosis. J Vasc Surg. 2020; 71(1): 149–57. doi: 10.1016/j.jvs.2019.04.487.

  37. Neil-Dwyer G., Bartlett J.R., Nicholls A.C. et al. Collagen deficiency and ruptured cerebral aneurysms. A clinical and biochemical study. J Neurosurg. 1983; 59(1): 16–20. doi: 10.3171/jns.1983.59.1.0016.

  38. Debette S., Germain D.P. Neurologic manifestations of inherited disorders of connective tissue. Handb Clin Neurol. 2014; 119: 565–76. doi: 10.1016/B978-0-7020-4086-3.00037-0.

  39. Pepin M., Schwarze U., Superti-Furga A., Byers P. Clinical and genetic features of Ehlers–Danlos syndrome type IV, the vascular type. N Engl J Med. 2000; 342(10): 673–80. doi: 10.1056/NEJM200003093421001.

  40. North K.N., Whiteman D.A., Pepin M.G., Byers P. Cerebrovascular complications in Ehlers–Danlos syndrome type IV. Ann Neurol. 1995; 38(6): 960–64. doi: 10.1002/ana.410380620.

  41. Schievink W.I., Limburg M., Oorthuys J.W.E. et al. Cerebrovascular disease in Ehlers–Danlos syndrome type IV. Stroke. 1990; 21(4): 626–32. doi: 10.1161/01.str.21.4.626.

  42. Schievink W.I. Cerebrovascular involvement in Ehlers–Danlos Syndrome. Curr Treat Options Cardiovasc Med. 2004; 6(3): 231–36. doi: 10.1007/s11936-996-0018-6.

  43. Loeys B.L., Chen J., Neptune E.R. et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet. 2005; 37(3): 275–81. doi: 10.1038/ng1511.

  44. Loeys B.L., Schwarze U., Holm T. et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med. 2006; 355(8): 788–98. doi: 10.1056/NEJMoa055695.

  45. Woolnough R., Dhawan A., Dow K., Walia J.S. Are patients with Loeys–Dietz syndrome misdiagnosed with beals syndrome? Pediatrics. 2017; 139(3): e20161281. doi: 10.1542/peds.2016-1281.

  46. Журавлева Л.В., Романенко А.Р. Поражение сердечно-сосудистой системы при наследственных заболеваниях соединительной ткани. Схiдноєвропейський журнал внутрiшньої та сiмейної медицини. 2016; 1: 104–110.

  47. LeMaire S.A., Pannu H., Tran-Fadulu V. et al. Severe aortic and arterial aneurysms associated with a TGFBR2 mutation. Nat Clin Pract Cardiovasc Med. 2007; 4: 167–71. doi: 10.1038/ncpcardio0797.

  48. MacCarrick G., Black J.H. 3rd, Bowdin S. et al. Loeys–Dietz syndrome: A primer for diagnosis and management. Genet Med. 2014; 16(8): 576–87. doi: 10.1038/gim.2014.11.

  49. Van Laer L., Dietz H., Loeys B. Loeys–Dietz syndrome. Adv Exp Med Biol. 2014; 802: 95–105. doi: 10.1007/978-94-007-7893-1_7.

  50. Hughes B.D., Powers C.J., Zomorodi A.R. Clipping of a cerebral aneurysm in a patient with Loeys–Dietz syndrome: Case report. Neurosurgery. 2011; 69: E746–E755. doi: 10.1227/NEU.0b013e31821964a3.

  51. 51. Kellner C.P., Sussman E.S., Donaldson C. et al. Cerebral arterial angioplasty in a patient with Loeys–Dietz syndrome. J Neurointerv Surg. 2015; 7(1): e2. doi: 10.1136/neurintsurg-2013-010857.rep.

  52. Levitt M.R., Morton R.P., Mai J.C. et al. Endovascular treatment of intracranial aneurysms in Loeys–Dietz syndrome. J Neurointerv Surg. 2012; 4(6): e37. doi: 10.1136/neurintsurg-2011-010138.

  53. Malhotra A., Westesson P.L. Loeys–Dietz syndrome. Pediatr Radiol. 2009; 39(9): 1015. doi: 10.1007/s00247-009-1252-3.

  54. Rahme R.J., Adel J.G., Bendok B.R. et al. Association of intracranial aneurysm and Loeys–Dietz syndrome: Case illustration, management, and literature review. Neurosurgery. 2011; 69: E488–E492. doi: 10.1227/NEU.0b013e318218cf55.

  55. Rodrigues V.J., Elsayed S., Loeys B.L. et al. Neuroradiologic manifestations of Loeys–Dietz syndrome type 1. AJNR. 2009; 30(8): 1614–19. doi: 10.3174/ajnr.A1651.

  56. Germain D.P. Pseudoxanthoma elasticum. Orphanet J Rare Dis. 2017; 12(1): 85. doi: 10.1186/s13023-017-0639-8.

  57. Struk B., Neldner K.H., Rao V.S. et al. Mapping of both autosomal recessive and dominant variants of pseudoxanthoma elasticum to chromosome 16p13.1. Hum Mol Genet. 1997; 6(11): 1823–28. doi: 10.1093/hmg/6.11.1823.

  58. Chassaing N., Martin L., Calvas P. et al. Pseudoxanthoma elasticum: a clinical, pathophys-iological and genetic update including 11 novel ABCC6 mutations. J Med Genet. 2005; 42(12): 881–92. doi: 10.1136/jmg.2004.030171.

  59. Neldner K.H. Pseudoxanthoma elasticum. Clin Dermatol. 1988; 6(1): 1–159. doi: 10.1016/0738-081x(88)90003-x.

  60. Marconi B., Bobyr I., Campanati A. et al. Pseudoxanthoma elasticum and skin: Clinical manifestations, histopathology, pathomechanism, perspectives of treatment. Intractable Rare Dis Res. 2015; 4(3): 113–22. doi: 10.5582/irdr.2015.01014.

  61. Van Loey S., Leys A. Pseudoxanthoma elasticum confirmed by genetic analysis but not by skin biopsy: A case report and review of the literature. Bull Soc Belge Ophtalmol. 2013; 322: 83–87.

  62. Georgalas I., Tservakis I., Papaconstaninou D. et al. Pseudoxanthoma elasticum, ocular manifestations, complications and treatment. Clin Exp Optom. 2011; 94(2): 169–80. doi: 10.1111/j.1444-0938.2010.00559.x.

  63. Leftheriotis G., Omarjee L., Le Saux O. et al. The vascular phenotype in pseudoxanthoma elasticum and related disorders: contribution of a genetic disease to the understanding of vascular calcification. Front Genet. 2013; 4: 4. doi: 10.3389/fgene.2013.00004.

  64. Germain D.P., Boutouyrie P., Laloux B., Laurent S. Arterial remodeling and stiffness in patients with pseudoxanthoma elasticum. Arterioscler Thromb Vasc Biol. 2003; 23(5): 836–41. doi: 10.1161/01.ATV.0000067428.19031.28.

  65. Kornet L., Bergen A.A., Hoeks A.P. et al. In patients with pseudoxanthoma elasticum a thicker and more elastic carotid artery is associated with elastin fragmentation and proteoglycans accumulation. Ultrasound Med Biol. 2004; 30(8): 1041–48. doi: 10.1016/j.ultrasmedbio.2004.06.004.

  66. Kupetsky-Rincon E.A., Li Q., Uitto J. Magnesium reduces carotid intima-media thickness in a mouse model of pseudoxanthoma elasticum: a novel treatment biomarker. Clin Transl Sci. 2012; 5(3): 259–64. doi: 10.1111/j.1752-8062.2011.00390.x.

  67. Eigenbrodt M.L., Bursac Z., Tracy R.E. et al. B-mode ultrasound common carotid artery intima-media thickness and external diameter: cross-sectional and longitudinal associations with carotid atherosclerosis in a large population sample. Cardiovasc Ultrasound. 2008; 6: 10. doi: 10.1186/1476-7120-6-10.

  68. Vanakker O.M., Leroy B.P., Coucke P. et al. Novel clinico-molecular insights in pseudoxanthoma elasticum provide an efficient molecular screening method and a comprehensive diagnostic flowchart. Hum Mutat. 2008; 29(1): 205. doi: 10.1002/humu.9514.

  69. Leftheriotis G., Abraham P., Le Corre Y. et al. Relationship between ankle brachial index and arterial remodeling in pseudoxanthoma elasticum. J Vasc Surg. 2011; 54(5): 1390–94. doi: 10.1016/j.jvs.2011.04.041.

  70. Zimmo L., Rudarakanchana N., Thompson M. et al. Renal artery aneurysm formation secondary to pseudoxanthoma elasticum. J Vasc Surg. 2013; 57(3): 842–44. doi: 10.1016/j.jvs.2012.09.016.

  71. van den Berg J.S., Hennekam R.C., Cruysberg J.R. et al. Prevalence of symptomatic intracranial aneurysm and ischaemic stroke in pseudoxanthoma elasticum. Cerebrovasc Dis. 2000; 10(4): 315–19. doi: 10.1159/000016076.

  72. Vasseur M., Carsin-Nicol B., Ebran J.M. et al. Carotid rete mirabile and pseudoxanthoma elasticum: an accidental association? Eur J Vasc Endovasc Surg. 2011; 42(3): 292–94. doi: 10.1016/j.ejvs.2011.05.007.

  73. Boutouyrie P., Germain D.P., Tropeano A.I. et al. Compressibility of the carotid artery in patients with pseudoxanthoma elasticum. Hypertension. 2001; 38(5): 1181–84. doi: 10.1161/hy1101.096108.

  74. Karam C., Soulat G., Germain D.P. et al. Coronary CT angiography for chest pain in pseudoxanthoma elasticum and cardiac intervention management. J Cardiovasc Comput Tomogr. 2015; 9(3): 238–41. doi: 10.1016/j.jcct.2015.02.004.


Об авторах / Для корреспонденции

Наталия Вячеславовна Пизова, д.м.н., профессор кафедры нервных болезней с медицинской генетикой и нейрохирургией ФГБОУ ВО «Ярославский государственный медицинский университет» Минздрава России. Адрес: 150030, г. Ярославль, Суздальское шоссе, д. 39. E-mail: pizova@yandex.ru. ORCID: 0000-0002-7465-0677
Николай Александрович Пизов, аспирант кафедры нервных болезней с медицинской генетикой и нейрохирургией ФГБОУ ВО «Ярославский государственный медицинский университет» Минздрава России. Адрес: 150030, г. Ярославль, Суздальское шоссе, д. 39. ORCID: 0000-0002-3009-3020
Ольга Александровна Скачкова, аспирант кафедры нервных болезней с медицинской генетикой и нейрохирургией ФГБОУ ВО «Ярославский государственный медицинский университет» Минздрава России. Адрес: 150030, г. Ярославль, Суздальское шоссе, д. 39. ORCID: 0000-0001-6825-1322
Владимир Александрович Шадричев, ассистент кафедры нервных болезней с медицинской генетикой и нейрохирургией ФГБОУ ВО «Ярославский государственный медицинский университет» Минздрава России. Адрес: 150030, г. Ярославль, Суздальское шоссе, д. 39. ORCID: 0000-0002-2340-007X


Похожие статьи

К содержанию номера

Бионика Медиа